These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34133038)

  • 1. Mucormycosis and glucose-regulated protein 78 in COVID-19: Amenable to statin treatment?
    Vuorio A; Kovanen PT
    J Intern Med; 2021 Oct; 290(4):931-933. PubMed ID: 34133038
    [No Abstract]   [Full Text] [Related]  

  • 2. Should statins be considered for the management of mucormycosis in COVID-19?
    Chatterjee S; Vardhan B; Singh DK; Maitra A; Ojha UK
    Diabetes Metab Syndr; 2021; 15(4):102162. PubMed ID: 34186353
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection.
    Surma S; Banach M; Lewek J
    Lipids Health Dis; 2021 Oct; 20(1):141. PubMed ID: 34689776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older Familial Hypercholesterolemia Patients with COVID-19.
    Vuorio A; Kovanen PT; Strandberg TE
    Gerontology; 2021; 67(5):608-610. PubMed ID: 33735871
    [No Abstract]   [Full Text] [Related]  

  • 5. The "Black Fungus" in India: The Emerging Syndemic of COVID-19-Associated Mucormycosis.
    Gandra S; Ram S; Levitz SM
    Ann Intern Med; 2021 Sep; 174(9):1301-1302. PubMed ID: 34097436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID19 associated mucormycosis: Is GRP78 a possible link?
    Gumashta J; Gumashta R
    J Infect Public Health; 2021 Oct; 14(10):1351-1357. PubMed ID: 34538732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia.
    Vuorio A; Kovanen PT
    J Clin Lipidol; 2020; 14(5):617-618. PubMed ID: 32653497
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins in COVID-19 infection: A rehash of old themes or truly a new hope?
    Jia X; Virani SS
    J Clin Lipidol; 2021; 15(3):399-401. PubMed ID: 33994121
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: Statins, COVID-19, and coronary artery disease: killing two birds with one stone.
    Ganjali S; Bianconi V; Penson PE; Pirro M; Banach M; Watts GF; Sahebkar A
    Metabolism; 2020 Dec; 113():154375. PubMed ID: 32976855
    [No Abstract]   [Full Text] [Related]  

  • 10. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Black fungus": a perspective on the coronavirus disease 2019 (COVID-19)-associated rhino-orbital mucormycosis epidemic in India.
    Thakar A; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1278-1279. PubMed ID: 34185968
    [No Abstract]   [Full Text] [Related]  

  • 12. GRP78: A possible relationship of COVID-19 and the mucormycosis; in silico perspective.
    Elgohary AM; Elfiky AA; Barakat K
    Comput Biol Med; 2021 Dec; 139():104956. PubMed ID: 34695683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of statin therapy in COVID-19.
    Daniels LB; Kumar K
    Expert Rev Cardiovasc Ther; 2022 Jun; 20(6):415-417. PubMed ID: 35608055
    [No Abstract]   [Full Text] [Related]  

  • 14. Statin rebound effect?
    Jones PJ
    J Lab Clin Med; 2003 Apr; 141(4):235-6. PubMed ID: 12677167
    [No Abstract]   [Full Text] [Related]  

  • 15. Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study.
    Yu Q; Su X; Liu E
    Int J Cardiol; 2016 Jan; 202():954-5. PubMed ID: 26549563
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG; Mohammed S; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucormycosis: An unanticipated progeny of COVID-19.
    Shrestha GS; Bhandari S; Lamsal R; Gurung U
    JNMA J Nepal Med Assoc; 2021 Sep; 59(241):965-967. PubMed ID: 35199723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting high-risk young patients for statin therapy.
    Gotto AM
    JAMA; 2004 Jul; 292(3):377-8. PubMed ID: 15265854
    [No Abstract]   [Full Text] [Related]  

  • 19. Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
    Barkas F; Milionis H; Anastasiou G; Liberopoulos E
    Med Hypotheses; 2021 Jan; 146():110452. PubMed ID: 33333472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulnerable plaque derived from aspirated thrombi in recurrent acute coronary syndrome with familial hypercholesterolemia despite intensive lipid-lowering statin therapy.
    Natsui H; Konishi T; Saiin K; Tamaki Y; Sato T; Takenaka S; Tada A; Mizuguchi Y; Kobayashi Y; Sato T; Kamada R; Kamiya K; Nagai T; Tanaka S; Anzai T
    Cardiol J; 2022; 29(2):362-363. PubMed ID: 35411933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.